Non-Current Liabilities
Total Liabilities
Amgen Total Liabilities decreased by 2.3% to $965M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.9%, from $984M to $965M. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows an upward trend with a 10.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ4 2018
Last reportedQ1 2026Apr 30, 2026
Metric ID:
total_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $562M | $554M | $876M | $1.2B | $1.43B | $1.89B | $1.67B | $1.53B | $1.56B | $1.41B | $1.19B | $1.17B | $1.13B | $998M | $1.13B | $984M | $1.11B | $999M | $988M | $965M |
| QoQ Change | — | -1.4% | +58.1% | +36.4% | +20.0% | +31.7% | -11.7% | -8.6% | +2.2% | -9.4% | -15.9% | -1.7% | -2.9% | -12.0% | +13.0% | -12.8% | +12.7% | -9.9% | -1.1% | -2.3% |
| YoY Change | — | — | — | — | +155.2% | +240.8% | +90.4% | +27.6% | +8.7% | -25.2% | -28.8% | -23.4% | -27.3% | -29.3% | -5.1% | -15.8% | -2.2% | +0.1% | -12.4% | -1.9% |
Range$554M – $1.89B
CAGR+12.1%
Avg YoY Growth+22.0%
Median YoY Growth-3.6%
Current Streak3 quarters decline
Total Liabilities at Other Companies
Frequently Asked Questions
- What is Amgen's total liabilities?
- Amgen (AMGN) reported total liabilities of $965M in Q1 2026.
- How has Amgen's total liabilities changed year-over-year?
- Amgen's total liabilities decreased by 1.9% year-over-year, from $984M to $965M.
- What is the long-term trend for Amgen's total liabilities?
- Over 5 years (2020 to 2025), Amgen's total liabilities has grown at a 10.4% compound annual growth rate (CAGR), from $603M to $988M.